IL10 and myeloid sarcoma: In patients with MS, vitamin D supplementations reduce the production of proinflammatory cytokine [16] and elevate the levels of anti-inflammatory cytokines such as transforming growth factor-beta (TGF-ß) and interleukin-10 (IL-10) [17,18].